𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes

✍ Scribed by Frank Neumann; Claudia Wagner; Boris Kubuschok; Stefan Stevanovic; Hans-Georg Rammensee; Michael Pfreundschuh

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
283 KB
Volume
53
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of an HLA-DR-restricted p
Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2
✍ Frank Neumann; Claudia Wagner; Stefan Stevanovic; Boris Kubuschok; Claudia Schor 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB

## Abstract The __SSX2__ gene encodes the tumor‐specific antigen HOM‐MEL‐40/SSX2 expressed in a broad spectrum of tumors of different origin, against which humoral and CD8^+^ T‐cell‐mediated MHC‐I‐restricted responses have been demonstrated. Searching for promiscuous MHC‐II‐restricted peptides that

Identification of a novel peptide derive
Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line
✍ Alexander B. H. Barker; Marco W. J. Schreurs; Gaalda Tafazzul; Annemiek J. De Bo 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 633 KB

## Abstract Cytotoxic T lymphocytes (CTL) reactive with human melanoma tumor cells occasionally display cross‐reactivity with normal melanocytes. Previously, we identified the melanocyte lineage‐specific antigen gp100 that is expressed by both melanoma cells and normal melanocytes, as a target anti